A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Background: Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is commonly used for patients with locally advanced breast cancer. Epirubicin is another anthracycline used in breast cancer but the concurrent use of epirubicin and taxane is not well-established. We co...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yao, Xin, Hosenpud, Janet, Chitambar, Christopher R., Charlson, John, Cheng, Yee Chung
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2012
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319980/
https://ncbi.nlm.nih.gov/pubmed/22481980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.3980
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky